Clearside Biomedical, Inc. (CLSD) has 65 open-market insider trades by 16 insiders since 2016. The most active filer is Clay Thorp, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Clay Thorp | Dir | — | 20 | $14.4M | 2025-02-24 |
| Bradford T. Whitmore | 10% Owner | — | 9 | $10.1M | 2024-02-07 |
| Robert Alexander Ingram | Dir10% Owner | — | 2 | $3.7M | 2016-06-07 |
| Douglas Reed M.D. | 10% Owner | — | 1 | $512K | 2017-01-19 |
| Hatteras Venture Advisors III, LLC | 10% Owner | — | 1 | $436K | 2017-01-19 |
| Gerald D. Cagle | Dir | — | 5 | $358K | 2018-06-25 |
| RusnanoMedInvest LLC | 10% Owner | — | 1 | $300K | 2016-06-07 |
| Daniel H. White | CEOPres | — | 3 | $168K | 2018-06-04 |
| Anthony S. Gibney | Dir | — | 1 | $130K | 2024-04-18 |
| Ngai Hang Victor Chong | Chief Medical Officer | — | 3 | $109K | 2024-11-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Clay Thorp | Director | Buy | $14K | 2025-02-24 |
| Ngai Hang Victor Chong | Chief Medical Officer | Buy | $37K | 2024-11-01 |
| Ngai Hang Victor Chong | Chief Medical Officer | Buy | $25K | 2024-06-24 |
| Benjamin R. Yerxa | Director | Buy | $10K | 2024-05-15 |
| Anthony S. Gibney | Director | Buy | $130K | 2024-04-17 |
| Ngai Hang Victor Chong | CHIEF MEDICAL OFFICER | Buy | $48K |
Companies that share insiders with CLSD, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-03-20 |
| Bradford T. Whitmore | 10% Owner | Buy | $1.2M | 2024-02-07 |
| George M. Lasezkay | CEO | Sell | $23K | 2024-01-19 |
| Charles A. Deignan | CFO | Sell | $17K | 2024-01-19 |
| Bradford T. Whitmore | 10% Owner | Buy | $151K | 2023-10-30 |
| Nancy J. Hutson | Director | Buy | $9K | 2023-10-03 |
| Clay Thorp | Director | Buy | $9K | 2023-09-25 |
| Thomas Ciulla | Chief Medical Officer | Sell | $20K | 2023-01-20 |
| Charles A. Deignan | CFO | Sell | $21K | 2023-01-19 |
| George M. Lasezkay | CEO | Sell | $29K | 2023-01-19 |